Skip to main content
Skip to main content
AGL logo

Agilon Health, Inc. (AGL)

$107.36 $-3.65 (-3.29%) |Weak · 31
Bottom line: SELL — our Council read (31/100) and AI Score (31/100) broadly agree.
MCap: $1.79B| P/E Ratio: -2.4| Vol: 255.8K| Target: $24.50 (-77.2%)| 52-wk range: $0.34 – $6.08
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Agilon Health, Inc. (AGL) trades at $107.36 with AI Score 31/100 (Grade D). Agilon Health, Inc. operates within the healthcare sector, focusing on providing services to seniors through primary care physicians. Market cap: $1.79B, Sector: Healthcare.

Price live · AI analysis from May 10, 2026
Agilon Health, Inc. operates within the healthcare sector, focusing on providing services to seniors through primary care physicians. As of December 31, 2021, it served approximately 238,000 senior members, including both Medicare Advantage and Medicare fee-for-service beneficiaries.

AGL stock analysis for 2026: Analysts have set a consensus price target of $24.50 for Agilon Health, Inc., suggesting 77.2% downside from the current price of $107.36. The AI MoonshotScore is 31/100, indicating a bearish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
SELL 31/100 · D

AGL: 1/1 perspectives are bearish.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Agilon Health, Inc. (AGL) Healthcare & Pipeline Overview

CEORonald Allan Williams
Employees1076
HeadquartersAustin, TX, US
IPO Year2021

Agilon Health, Inc. delivers healthcare services for seniors via primary care physicians across the United States. The company focuses on Medicare Advantage and fee-for-service beneficiaries, offering a value-based care model within the evolving healthcare landscape. It aims to improve outcomes and reduce costs for its senior patient population.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for AGL?

Agilon Health presents a compelling, yet risky, investment case centered on its value-based care model for seniors. The company's focus on Medicare Advantage and fee-for-service beneficiaries positions it to capitalize on the growing demand for senior-focused healthcare solutions. However, with a current market cap of $1.79B and negative profit and gross margins of -6.4% and -2.7% respectively, the company's financial performance raises concerns. Key to Agilon's success will be its ability to scale its operations, improve its financial metrics, and demonstrate the effectiveness of its care model in reducing healthcare costs and improving patient outcomes. The company's low beta of 0.11 suggests relatively low volatility compared to the broader market.

Based on FMP financials and quantitative analysis

AGL Key Highlights

  • Served approximately 238,000 senior members as of December 31, 2021, indicating a substantial patient base.
  • Includes 186,300 Medicare Advantage members, highlighting a significant presence in the managed care segment.
  • Includes 51,700 Medicare fee-for-service beneficiaries, demonstrating a diversified revenue stream.
  • Market capitalization of $1.79B, reflecting the company's current valuation.
  • Negative profit margin of -6.4%, indicating challenges in achieving profitability.

Who Are AGL's Competitors?

AGL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
HWAIF Healwell AI Inc. $0.53 -3.52% $160.75M 65
ASSF Assisted 4 Living, Inc. $1.00 +0.00% $45.35M 63
FTRP Field Trip Health Ltd. $0.84 +1.07% $9.81M 62
SLHGP Skylight Health Group Inc. $12.00 -5.88% 61
NWKHY Netcare Limited $7.17 +0.00% $843.64M 50
AONC American Oncology Network, Inc. $10.00 +0.00% $292.48M 50
DCGO DocGo Inc. $0.59 +5.81% $58.07M 51
JYNT The Joint Corp. $9.16 +2.10% $130.55M 51

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AGL's Key Strengths?

  • Established network of primary care physician partners.
  • Focus on value-based care.
  • Proprietary data analytics capabilities.
  • Strong relationships with Medicare Advantage plans.

What Are AGL's Weaknesses?

  • Negative profit and gross margins.
  • Limited geographic presence.
  • Dependence on government reimbursement policies.
  • Relatively small market capitalization.

What Could Drive AGL Stock Higher?

  • Expansion into new geographic markets, increasing the company's reach and patient base.
  • Continued growth in Medicare Advantage enrollment, driving revenue growth.
  • Development and launch of new service offerings, enhancing the company's value proposition.
  • Strategic partnerships and acquisitions, expanding the company's capabilities and market share.

What Are the Key Risks for AGL?

  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Regulatory changes and reimbursement pressures, impacting the company's financial performance.
  • Increased competition from established healthcare providers, reducing the company's market share.
  • Economic downturn and reduced healthcare spending, affecting the company's revenue.
  • Cybersecurity risks and data breaches, compromising patient data and damaging the company's reputation.
  • Negative profit and gross margins, indicating challenges in achieving profitability.

What Are the Growth Opportunities for AGL?

  • Expansion into New Geographic Markets: Agilon Health has the opportunity to expand its presence into new geographic markets, both domestically and potentially internationally. By partnering with primary care physicians in underserved areas, the company can increase its patient base and revenue streams. The market for senior healthcare is growing rapidly, with an estimated market size of $1 trillion annually in the United States alone. Timeline: Ongoing expansion efforts with potential for accelerated growth over the next 3-5 years.
  • Increased Penetration of Existing Markets: Agilon can further penetrate its existing markets by deepening its relationships with primary care physicians and attracting more senior members. By demonstrating the value of its care model and providing enhanced support to physicians, the company can increase its market share and improve patient outcomes. The potential market size within existing regions is estimated to be $500 billion. Timeline: Continuous improvement and expansion within current markets over the next 1-3 years.
  • Development of New Service Offerings: Agilon has the opportunity to develop new service offerings that cater to the evolving needs of its senior members. This could include telehealth services, chronic disease management programs, and specialized care for specific conditions. The market for telehealth services is projected to reach $175 billion by 2026. Timeline: Gradual rollout of new services over the next 2-4 years.
  • Strategic Partnerships and Acquisitions: Agilon can pursue strategic partnerships and acquisitions to expand its capabilities and reach. This could include partnering with technology companies, healthcare providers, or other organizations that complement its existing business. The market for healthcare partnerships and acquisitions is highly active, with numerous opportunities available. Timeline: Ongoing evaluation of potential partnerships and acquisitions.
  • Leveraging Data and Analytics: Agilon can leverage its data and analytics capabilities to improve patient outcomes, reduce costs, and optimize its operations. By analyzing patient data and identifying trends, the company can develop targeted interventions and personalized care plans. The market for healthcare analytics is projected to reach $50 billion by 2025. Timeline: Continuous improvement and innovation in data analytics capabilities.

What Opportunities Does AGL Have?

  • Expansion into new geographic markets.
  • Increased penetration of existing markets.
  • Development of new service offerings.
  • Strategic partnerships and acquisitions.

What Threats Does AGL Face?

  • Regulatory changes and reimbursement pressures.
  • Increased competition from established healthcare providers.
  • Economic downturn and reduced healthcare spending.
  • Cybersecurity risks and data breaches.

What Are AGL's Competitive Advantages?

  • Established network of primary care physician partners.
  • Proprietary data analytics and technology platform.
  • Focus on value-based care and improved health outcomes.
  • Strong relationships with Medicare Advantage plans.

What Does AGL Do?

Agilon Health, Inc., established in 2016 and headquartered in Austin, Texas, is dedicated to transforming healthcare for seniors. The company partners with primary care physicians (PCPs) in various communities throughout the United States, enabling them to deliver comprehensive, value-based care. Agilon's model focuses on improving health outcomes and reducing the overall cost of care for its senior members. As of December 31, 2021, Agilon served approximately 238,000 senior members, including 186,300 Medicare Advantage members and 51,700 Medicare fee-for-service beneficiaries. Agilon Health operates by aligning incentives between PCPs and the healthcare system, facilitating a shift from a fee-for-service model to one that emphasizes proactive and preventative care. This approach allows physicians to focus on the unique needs of their senior patients, leading to better health management and reduced hospitalizations. The company provides its partner physicians with data analytics, technology, and administrative support to enhance their ability to deliver high-quality care. Agilon Health was formerly known as Agilon Health Topco, Inc., changing its name in March 2021, reflecting its continued growth and evolution in the healthcare sector.

What Products and Services Does AGL Offer?

  • Provides healthcare services for seniors through primary care physicians.
  • Partners with primary care physicians in communities across the United States.
  • Serves Medicare Advantage members.
  • Serves Medicare fee-for-service beneficiaries.
  • Offers a value-based care model.
  • Focuses on improving health outcomes and reducing healthcare costs.

How Does AGL Make Money?

  • Partners with primary care physicians to deliver value-based care.
  • Receives payments from Medicare Advantage plans and Medicare fee-for-service programs.
  • Provides physicians with data analytics, technology, and administrative support.
  • Shares cost savings and improved outcomes with physicians.

What Industry Does AGL Operate In?

Agilon Health operates within the rapidly evolving healthcare industry, specifically targeting the senior care segment. The aging population and increasing prevalence of chronic diseases are driving demand for innovative healthcare solutions that prioritize value-based care. The competitive landscape includes established healthcare providers, managed care organizations, and emerging technology companies. Agilon's success depends on its ability to differentiate itself through its physician partnership model, data-driven insights, and focus on improving health outcomes for seniors. The industry is also subject to regulatory changes and reimbursement policies, which can impact Agilon's financial performance and growth prospects.

Who Are AGL's Key Customers?

  • Senior citizens enrolled in Medicare Advantage plans.
  • Senior citizens who are Medicare fee-for-service beneficiaries.
  • Primary care physicians who partner with Agilon Health.
  • Healthcare systems and providers seeking to improve care for seniors.
AI Confidence: 64% Updated: May 10, 2026

Company Profile

Agilon Health, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Austin, US. The company is led by CEO Ronald Allan Williams. AGL has traded publicly since 2021.

Key Financial Metrics

Return on assets is -24.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -5.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.04 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -25.5%, the inverse of the P/E and a quick read on earnings relative to price.

AGL Valuation & Market Position

With a $1.79B market cap, Agilon Health, Inc. sits in the small-cap segment of the market. Relative to its peer group, AGL's quantitative score of 31/100 is below the peer average of 60/100.

Quarterly Financial Performance: Agilon Health, Inc.

Revenue for Agilon Health, Inc. came in at $1.42B during Q1 2026, a 9.5% contraction versus the preceding quarter. The company recorded net income of $30.0M, with diluted EPS of $1.80. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, AGL averaged $-5.67 in diluted EPS.

F-Score 3/9Financial Health

Agilon Health, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 2.14 places it in the grey zone, a middle ground that warrants monitoring.

FY2026 estForward Outlook

Wall Street analysts project Agilon Health, Inc. revenue of about $5.72B for fiscal 2026, with EPS near $-2.84. The estimate reflects 11 contributing analysts.

AGL Financials

Fundamental Snapshot

Revenue Growth (FY)
-2.1%
Net Income Growth (FY)
-55.8%
EPS Growth (FY)
-55.6%
Free Cash Flow Growth (FY)
-67.5%
Return on Equity (TTM)
-146.0%
Current Ratio
1.0

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Agilon Health's recent insider buying suggests confidence from those closest to the company's operations.
  • Community sentiment indicates a belief in Agilon's long-term strategy within the value-based care model.
  • The market seems to be acknowledging Agilon's potential for growth as healthcare shifts towards preventative care.
  • Positive community discussions highlight Agilon's partnerships and expansion into new geographic markets.

Bear Case

  • Some community members express concern about Agilon's ability to scale its operations effectively.
  • Recent market volatility has created uncertainty around growth stocks like Agilon, impacting investor sentiment.
  • There are worries among some traders about increasing competition in the value-based care sector.
  • Negative sentiment surfaces occasionally regarding the complexity of healthcare regulations and their potential impact on Agilon.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · February 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q1 2026 $1.42B $30M $1.80
Q4 2025 $1.57B -$189M -$11.50
Q3 2025 $1.44B -$110M -$6.75
Q2 2025 $1.39B -$104M -$6.25

Based on FMP financials and quantitative analysis

AGL Latest News

AGL Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AGL.

Price Targets

Consensus target: $24.50

AGL MoonshotScore

31/100

What does this score mean?

The MoonshotScore rates AGL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Latest Agilon Health, Inc. Analysis

Leadership: Ronald Allan Williams

CEO

Ronald Allan Williams serves as the CEO of Agilon Health, Inc., managing a workforce of 1076 employees. His extensive background in healthcare leadership positions him to guide the company's strategic direction and growth initiatives. Prior to joining Agilon Health, Williams held various executive roles in the healthcare industry, demonstrating his expertise in healthcare management, operations, and innovation. His experience includes leading large-scale healthcare organizations and driving improvements in patient care and financial performance. Williams' leadership is crucial in navigating the complexities of the healthcare market and achieving Agilon Health's mission of transforming healthcare for seniors.

Track Record: Under Ronald Allan Williams' leadership, Agilon Health has focused on expanding its network of primary care physician partners and enhancing its value-based care model. Key milestones include increasing the number of senior members served and improving patient outcomes. Williams has also overseen the company's efforts to leverage data analytics and technology to optimize its operations and deliver personalized care. His strategic decisions have been instrumental in positioning Agilon Health for continued growth and success in the evolving healthcare landscape.

Common Questions About AGL (Healthcare)

What does Agilon Health, Inc. do?

Agilon Health, Inc. operates as a healthcare service provider focused on seniors, partnering with primary care physicians across the United States. The company's core business model revolves around delivering value-based care to Medicare Advantage and fee-for-service beneficiaries. By equipping physicians with data analytics, technology, and administrative support, Agilon aims to improve patient outcomes, reduce healthcare costs, and enhance the overall quality of care for its senior members. The company's market position is strengthened by its established network of physician partners and its focus on proactive, preventative care.

What do analysts say about AGL stock?

Analyst coverage of Agilon Health (AGL) is limited, reflecting its relatively small market capitalization and recent financial performance. Current sentiment is cautiously optimistic, acknowledging the company's growth potential in the senior healthcare market but also highlighting the risks associated with its negative profit margins. Key valuation metrics, such as price-to-sales ratio, are being closely monitored to assess the company's future earnings potential. Analysts are also focused on Agilon's ability to scale its operations, improve its financial metrics, and demonstrate the effectiveness of its care model in reducing healthcare costs.

What are the main risks for AGL?

Agilon Health faces several key risks, including regulatory changes, reimbursement pressures, and increased competition. Changes in government policies related to Medicare Advantage and fee-for-service programs could significantly impact the company's revenue and profitability. Increased competition from established healthcare providers and emerging technology companies could erode Agilon's market share. Additionally, economic downturns and reduced healthcare spending could negatively affect the company's financial performance. Cybersecurity risks and data breaches also pose a threat to patient data and the company's reputation.

What are the key factors to evaluate for AGL?

Agilon Health, Inc. (AGL) holds an AI score of 31/100 (low). Analysts target $24.50 (-77%). Not financial advice.

How frequently does AGL data refresh on this page?

AGL prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven AGL's recent stock price performance?

Agilon Health, Inc. (AGL) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established network of primary care physician partners. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider AGL overvalued or undervalued right now?

Valuing Agilon Health, Inc. (AGL) requires multiple metrics. Analysts target $24.50 (-77%) — downside risk seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying AGL?

Before investing in Agilon Health, Inc. (AGL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information as of 2021.
  • Competitive landscape analysis is based on publicly available information and may not be exhaustive.
Data Sources

Popular Stocks